A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis.
10.3350/kjhep.2008.14.1.97
- Author:
Jae Young YOON
1
;
Sun Yang MIN
;
Ju Yee PARK
;
Seung Goun HONG
;
Sang Jong PARK
;
So Ya PAIK
;
Young Min PARK
Author Information
1. Department of Internal Medicine, Bundang Jesaeng General Hospital, Daejin Medical Center, Seongnam, Korea. ympark@dmc.or.kr
- Publication Type:Case Report ; English Abstract
- Keywords:
Allopurinol;
Cholestasis;
Granulomatous hepatitis;
Ductopenia
- MeSH:
Aged;
Allopurinol/*adverse effects/therapeutic use;
Antimetabolites/*adverse effects/therapeutic use;
Bile Duct Diseases/*chemically induced/diagnosis/pathology;
Bile Ducts, Intrahepatic/*drug effects/pathology;
Cholestasis/*chemically induced/diagnosis/pathology;
Drug Eruptions/pathology;
Granuloma/*chemically induced/pathology;
Hepatitis, Toxic/*pathology;
Humans;
Kidney Failure, Chronic/complications/drug therapy;
Male
- From:The Korean Journal of Hepatology
2008;14(1):97-101
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Allopurinol-induced hypersensitivity syndrome is characterized by an idiosyncratic reaction involving multiple-organs, which usually begins 2 to 6 weeks after starting allopurinol. In rare cases, the adverse reactions to allopurinol are accompanied by a variety of liver injury, such as reactive hepatitis, granulomatous hepatitis, vanishing bile duct syndrome, or fulminant hepatic failure. Here we report a case with granulomatous hepatitis and ductopenia. A 69-year-old man with chronic renal failure, hyperuricemia, and previously normal liver function presented with jaundice, skin rash, and fever 2 weeks after taking allopurinol (200 mg/day). In histopathology, a liver biopsy specimen showed mild spotty necrosis of hepatocytes, marked cholestasis in parenchyma, and some granulomas in the portal area. There were vacuolar degeneration in the interlobular bile ducts and ductopenia in the portal tracts. Pathologic criteria strongly suggested the presence of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis. The patient fully recovered following the early administration of systemic corticosteroid therapy.
